These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 76845)

  • 41. [Treatment of dialysis encephalopathy with deferoxamine].
    Starkstein S; Berthier M; Nogués M; Leiguarda R
    Medicina (B Aires); 1986; 46(3):327-31. PubMed ID: 3574092
    [No Abstract]   [Full Text] [Related]  

  • 42. Progressive dialysis encephalopathy from dialysate aluminum.
    Rozas VV; Port FK; Rutt WM
    Arch Intern Med; 1978 Sep; 138(9):1375-7. PubMed ID: 686928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.
    Morinière P; Fournier A; Leflon A; Hervé M; Sebert JL; Grégoire I; Bataille P; Guéris J
    Nephron; 1985; 39(4):309-15. PubMed ID: 3982576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM; Allen KR; Newton KE
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 46. [Two forerunners of the encephalopathy of hemodialysed patients : osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)].
    Vecchierini-Blineau MF; Thébaud HE; Brochard D; Coville P
    Nephrologie; 1980; 1(1):29-32. PubMed ID: 7301017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some aspects related to the presence of aluminium in waters.
    Giordano R; Costantini S
    Ann Ist Super Sanita; 1993; 29(2):305-11. PubMed ID: 8279721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aluminum toxicity in relation to kidney disorders.
    King SW; Savory J; Wills MR
    Ann Clin Lab Sci; 1981; 11(4):337-42. PubMed ID: 7023347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Water content of aluminum, dialysis dementia, and osteomalacia.
    Wills MR; Savory J
    Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An outbreak of dialysis dementia due to aluminum in the dialysate.
    Rozas VV; Port FK; Easterling RE
    J Dial; 1978; 2(5-6):459-70. PubMed ID: 750612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dialysis encephalopathy associated with polyvalent ion contamination.
    Hocken AG
    N Z Med J; 1984 Mar; 97(752):190-2. PubMed ID: 6583579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency.
    Zumkley H; Bertram HP; Lison A; Knoll O; Losse H
    Clin Nephrol; 1979 Jul; 12(1):18-21. PubMed ID: 477052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
    Milne FJ; Sharf B; Bell P; Meyers AM
    Clin Nephrol; 1983 Oct; 20(4):202-7. PubMed ID: 6641027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental aluminium encephalopathy: quantitative EEG analysis of aluminium bioavailability.
    Cutrufo C; Caroli S; Delle Femmine P; Ortolani E; Palazzesi S; Violante N; Zapponi GA; Loizzo A
    J Neurol Neurosurg Psychiatry; 1984 Feb; 47(2):204-6. PubMed ID: 6707660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study.
    Dahl E; Nordal KP; Halse J; Flatmark A
    Nephrol Dial Transplant; 1990; 5(6):449-56. PubMed ID: 2122323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Presence of high concentrations of aluminum in neurons of a patient dying from a rapidly developing dementia].
    Galle P; Meyrignac C; Heine P
    C R Acad Sci III; 1984; 299(13):535-9. PubMed ID: 6437618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. International Workshop on the role of biological monitoring in the prevention of aluminium toxicity in man: "Aluminium Analysis in Biological Fluids," Luxembourg, July 5-7, 1982. Memorandum on the summary and conclusions.
    J Toxicol Clin Toxicol; 1982 Oct; 19(8):907-10. PubMed ID: 7182518
    [No Abstract]   [Full Text] [Related]  

  • 58. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG; Pødenphant J; Andersen JR
    Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of aluminium intoxication in long-term acetate Redy dialysis.
    Van de Vyver FL; Visser WJ; D'Haese PC; Silva FJ; Thomas H; De Broe ME
    Nephrol Dial Transplant; 1989; 4(6):555-62. PubMed ID: 2507978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can low-dosage aluminium hydroxide control the plasma phosphate without bone toxicity?
    Jenkins DA; Gouldesbrough D; Smith GD; Cowie JF; Winney RJ
    Nephrol Dial Transplant; 1989; 4(1):51-6. PubMed ID: 2494599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.